Great stories about patents and other IP

Suven jumps 5% on patents in China, Eurasia, Hong Kong

Source: moneycontrol, by:Rakesh Patil

ip-suven-patents-china-1300-860This patents are equivalent to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurode generative diseases and are valid through 2032.

Moneycontrol Bureau Shares of Suven Life Sciences gained 5 percent intraday Monday as it has bagged 3 product patent from China, Eurasia and Hong Kong each. This patents are equivalent to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurode generative diseases and are valid through 2032.
With this, company has a total of 20 granted patents from China, 16 granted product patents from Eurasia and 19 granted product patents from Hong Kong Venkat Jasti, CEO of Suven said, “We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally.”
At 11:15 hrs Suven Life Sciences was quoting at Rs 207, up Rs 6.20, or 3.09 percent on the BSE.

Tags: , , , , , , , , ,
grill-ip

Author: grill-ip

Grill IP is a non-profit project for educational and entertaining purposes only. Our aim is to provide quick and easy access to aggregated and original patent news, IP analysis, interesting business cases in IP, basic legal updates and a list of patent transactions.

Share This Post On

Submit a Comment

Your email address will not be published. Required fields are marked *

Share This